Oscar Health, Inc. (NYSE:OSCR - Get Free Report) shares reached a new 52-week low on Thursday . The stock traded as low as $12.25 and last traded at $12.97, with a volume of 596745 shares traded. The stock had previously closed at $13.37.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on OSCR. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 target price on the stock. Two analysts have rated the stock with a sell rating, three have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $20.21.
Get Our Latest Stock Analysis on Oscar Health
Oscar Health Price Performance
The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The firm's fifty day moving average is $14.53 and its two-hundred day moving average is $15.68. The company has a market cap of $3.02 billion, a P/E ratio of -600.95 and a beta of 1.75.
Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Institutional Trading of Oscar Health
Several hedge funds have recently bought and sold shares of OSCR. State Street Corp increased its holdings in shares of Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock worth $108,867,000 after purchasing an additional 291,335 shares during the last quarter. Lingotto Investment Management LLP bought a new stake in Oscar Health in the 4th quarter worth approximately $2,543,000. GDS Wealth Management increased its stake in Oscar Health by 1,545.3% in the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company's stock worth $4,648,000 after acquiring an additional 324,798 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of Oscar Health by 296.0% during the 4th quarter. Victory Capital Management Inc. now owns 231,059 shares of the company's stock worth $3,105,000 after acquiring an additional 172,706 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Oscar Health during the 4th quarter valued at approximately $5,672,000. Hedge funds and other institutional investors own 75.70% of the company's stock.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
